5 1 CBD FOR ACNE Cannabidiol as a Treatment for Acne? 1 CBD FOR ACNE Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes 1 CBD FOR ACNE The endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities 1 CBD FOR ACNE Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling 1 CBD FOR ACNE Endocannabinoid signaling and epidermal differentiation 6 2 CBD FOR ADD / ADHD Searching for a Neurobiological Basis for Self-Medication Theory in ADHD Comorbid With Substance Use Disorders 2 CBD FOR ADD / ADHD Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats 2 CBD FOR ADD / ADHD Subtypes of Attention Deficit — Hyperactivity Disorder (ADHD) and cannabis use 2 CBD FOR ADD / ADHD Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students 2 CBD FOR ADD / ADHD Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: A case report 2 CBD FOR ADD / ADHD Fitness to drive in spite (because) of THC 10 3 CBD FOR ADDICTION Cannabidiol reduces cigarette consumption in tobacco smokers 3 CBD FOR ADDICTION Cannabidiol inhibits the reward-facilitating effect of morphine 3 CBD FOR ADDICTION Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances 3 CBD FOR ADDICTION Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats 3 CBD FOR ADDICTION Impact of Cannabis Use during Stabilization on Methadone Maintenance Treatment 3 CBD FOR ADDICTION Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010 3 CBD FOR ADDICTION Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents 3 CBD FOR ADDICTION Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity 3 CBD FOR ADDICTION Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder 3 CBD FOR ADDICTION Cannabidiol for the treatment of cannabis withdrawal syndrome 4 4 CBD FOR ALS Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials 4 CBD FOR ALS ALS: delayed disease progression in mice by treatment with a cannabinoid 4 CBD FOR ALS The (Endo)Cannabinoid System in Multiple Sclerosis and ALS 4 CBD FOR ALS Survey of cannabis use in patients with ALS 16 5 CBD FOR ALZHEIMERS The therapeutic potential of the endocannabinoid system for Alzheimer’s disease 5 CBD FOR ALZHEIMERS Endocannabinoid signalling in Alzheimer’s disease 5 CBD FOR ALZHEIMERS A molecular link between the active component of marijuana and Alzheimer’s disease pathology 5 CBD FOR ALZHEIMERS Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells 5 CBD FOR ALZHEIMERS The Potential Therapeutic Effects of THC on Alzheimer’s Disease 5 CBD FOR ALZHEIMERS The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease 5 CBD FOR ALZHEIMERS Cannabinoids for the treatment of dementia 5 CBD FOR ALZHEIMERS Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression 5 CBD FOR ALZHEIMERS Cannabidiol: A promising drug for neurodegenerative disorders? 5 CBD FOR ALZHEIMERS Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition 5 CBD FOR ALZHEIMERS The role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses 5 CBD FOR ALZHEIMERS The role of phytochemicals in the treatment and prevention of dementia 5 CBD FOR ALZHEIMERS Cannabinoids for the treatment of dementia 5 CBD FOR ALZHEIMERS Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement 5 CBD FOR ALZHEIMERS Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic 5 CBD FOR ALZHEIMERS Can Marijuana Prevent Alzheimer’s? 4 6 CBD FOR ANOREXIA Leptin, ghrelin, and endocannabinoids: Potential therapeutic targets in anorexia nervosa 6 CBD FOR ANOREXIA The role of the endocannabinoid system in eating disorders: Neurochemical and behavioural preclinical evidence 6 CBD FOR ANOREXIA Cancer cachexia and cannabinoids 6 CBD FOR ANOREXIA Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa 9 7 CBD FOR ANXIETY Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug 7 CBD FOR ANXIETY Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa 7 CBD FOR ANXIETY Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients 7 CBD FOR ANXIETY Neural basis of anxiolytic effects of cannabidiol ( CBD) in generalized social anxiety disorder 7 CBD FOR ANXIETY Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation 7 CBD FOR ANXIETY Effects of cannabidiol ( CBD) on regional cerebral blood flow 7 CBD FOR ANXIETY The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors 7 CBD FOR ANXIETY The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system 7 CBD FOR ANXIETY Plant-based medicines for anxiety disorders, part 2: A review of clinical studies with supporting preclinical evidence 4 8 CBD FOR ATHEROSCLEROSIS The role of the endocannabinoid system in atherosclerosis 8 CBD FOR ATHEROSCLEROSIS Cannabinoid receptors in atherosclerosis 8 CBD FOR ATHEROSCLEROSIS The potential use of cannabidiol in the therapy of metabolic syndrome 8 CBD FOR ATHEROSCLEROSIS Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice 4 9 CBD FOR ARTHRITIS Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis 9 CBD FOR ARTHRITIS The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis 9 CBD FOR ARTHRITIS The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55 9 CBD FOR ARTHRITIS Arthritis and cannabinoids 5 10 CBD FOR ASTHMA The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke 10 CBD FOR ASTHMA Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma 10 CBD FOR ASTHMA Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs 10 CBD FOR ASTHMA Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways 10 CBD FOR ASTHMA Bronchodilator effect of delta1-tetrahydrocannabinol 5 11 CBD FOR AUTISM Mutations found in individuals with autism interfere with endocannabinoid signaling in the brain 11 CBD FOR AUTISM Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders 11 CBD FOR AUTISM A novel approach to the symptomatic treatment of autism 11 CBD FOR AUTISM Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders 11 CBD FOR AUTISM Targeting the endocannabinoid system in the treatment of fragile X syndrome 5 12 CBD FOR BIPOLAR AFFECTIVE DISORDER Cannabinoids in bipolar affective disorder: A review and discussion of their therapeutic potential 12 CBD FOR BIPOLAR AFFECTIVE DISORDER Cannabidiol was ineffective for manic episode of bipolar affective disorder 12 CBD FOR BIPOLAR AFFECTIVE DISORDER Effects of Co-occurring Cannabis Use Disorders on the Course of Bipolar Disorder After a First Hospitalization for Mania 12 CBD FOR BIPOLAR AFFECTIVE DISORDER Does Cannabis Use Affect Treatment Outcome in Bipolar Disorder?: A Longitudinal Analysis 12 CBD FOR BIPOLAR AFFECTIVE DISORDER The Use of Cannabis as a Mood Stabilizer in Bipolar Disorder: Anecdotal Evidence and the Need for Clinical Research 5 13 CBD FOR CANCER – GENERAL Cannabidiol as potential anticancer drug 13 CBD FOR CANCER – GENERAL Cannabidiol inhibits angiogenesis by multiple mechanisms 13 CBD FOR CANCER – GENERAL The inhibitory effects of cannabidiol on systemic malignant tumors 13 CBD FOR CANCER – GENERAL Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1 13 CBD FOR CANCER – GENERAL Marijuana fights cancer and helps manage side effects 4 14 CBD FOR CANCER – LUNG Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1C 14 CBD FOR CANCER – LUNG COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells 14 CBD FOR CANCER – LUNG Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells 14 CBD FOR CANCER – LUNG Media ignored expert’s shocking findings that marijuana helps prevent lung cancer 5 15 CBD FOR CANCER – PROSTATE/COLON Towards the use of non-psychoactive cannabinoids for prostate cancer 15 CBD FOR CANCER – PROSTATE/COLON In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines 15 CBD FOR CANCER – PROSTATE/COLON Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent 15 CBD FOR CANCER – PROSTATE/COLON Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer 15 CBD FOR CANCER – PROSTATE/COLON Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol 5 16 CBD FOR CANCER – BREAST Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma 16 CBD FOR CANCER – BREAST Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy 16 CBD FOR CANCER – BREAST Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis 16 CBD FOR CANCER – BREAST Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells 16 CBD FOR CANCER – BREAST Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration 8 17 CBD FOR CANCER – BRAIN Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival 17 CBD FOR CANCER – BRAIN Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines(PubMed) 17 CBD FOR CANCER – BRAIN Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas 17 CBD FOR CANCER – BRAIN Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism 17 CBD FOR CANCER – BRAIN Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target 17 CBD FOR CANCER – BRAIN Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents 17 CBD FOR CANCER – BRAIN Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect 17 CBD FOR CANCER – BRAIN Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme 4 18 CBD FOR CANCER – LEUKEMIA Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression 18 CBD FOR CANCER – LEUKEMIA Cannabidiol-Induced Apoptosis in Human Leukemia Cells 18 CBD FOR CANCER – LEUKEMIA Cannabidiol Reduces Leukemic Cell Size – But Is It Important? 18 CBD FOR CANCER – LEUKEMIA Targeting cannabinoid receptors to treat leukemia 4 19 CBD FOR CANCER – SKIN Anticancer activity of anandamide in human cutaneous melanoma cells 19 CBD FOR CANCER – SKIN Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpes virus-infected endothelium (PubMed) 19 CBD FOR CANCER – SKIN Cannabinoid receptors as novel targets for the treatment of melanoma 19 CBD FOR CANCER – SKIN The Cannabinoid Receptors Are Required for Ultraviolet-Induced Inflammation and Skin Cancer Development 4 20 CBD FOR CANCER – ENDOCRINE Endocannabinoids in endocrine and related tumours 20 CBD FOR CANCER – ENDOCRINE A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells 20 CBD FOR CANCER – ENDOCRINE Cannabinoids in pancreatic cancer: Correlation with survival and pain 20 CBD FOR CANCER – ENDOCRINE Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma 4 21 CBD FOR CANCER – BLADDER TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer 21 CBD FOR CANCER – BLADDER Association Between Cannabis Use and the Risk of Bladder Cancer 21 CBD FOR CANCER – BLADDER Inhibitory Effect of Standardized Cannabis sativaExtract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility 21 CBD FOR CANCER – BLADDER Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism 4 22 CBD FOR CANCER – PAIN RELIEF Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain 22 CBD FOR CANCER – PAIN RELIEF Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial 22 CBD FOR CANCER – PAIN RELIEF Marijuana extract helps prevent chemo pain 22 CBD FOR CANCER – PAIN RELIEF An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/ CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics 10 23 CBD FOR CROHNS & COLITIS Cannabidiol in inflammatory bowel diseases: a brief overview 23 CBD FOR CROHNS & COLITIS Cannabis finds its way into treatment of Crohn’s disease 23 CBD FOR CROHNS & COLITIS Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis 23 CBD FOR CROHNS & COLITIS Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis 23 CBD FOR CROHNS & COLITIS The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis 23 CBD FOR CROHNS & COLITIS Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice 23 CBD FOR CROHNS & COLITIS Cannabinoids and the gut: New developments and emerging concepts 23 CBD FOR CROHNS & COLITIS Endocannabinoids and the gastrointestinal tract 23 CBD FOR CROHNS & COLITIS Cannabinoids and gastrointestinal motility: Animal and human studies 23 CBD FOR CROHNS & COLITIS Hergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis 11 24 CBD FOR DEPRESSION Endocannabinoid system dysfunction in mood and related disorders 24 CBD FOR DEPRESSION Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa 24 CBD FOR DEPRESSION The endocannabinoid system and the treatment of mood and anxiety disorders 24 CBD FOR DEPRESSION Endocannabinoid signaling in the etiology and treatment of major depressive illness 24 CBD FOR DEPRESSION Antidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors 24 CBD FOR DEPRESSION Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants 24 CBD FOR DEPRESSION Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa 24 CBD FOR DEPRESSION Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress 24 CBD FOR DEPRESSION Serum contents of endocannabinoids are correlated with blood pressure in depressed women 24 CBD FOR DEPRESSION The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants 24 CBD FOR DEPRESSION Antidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures 21 25 CBD FOR ENDOCRINE DISORDERS Endocannabinoid system participates in neuroendocrine control of homeostasis 25 CBD FOR ENDOCRINE DISORDERS The emerging role of the endocannabinoid system in endocrine regulation and energy balance 25 CBD FOR ENDOCRINE DISORDERS Endocannabinoids in endocrine and related tumours 25 CBD FOR ENDOCRINE DISORDERS Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas 25 CBD FOR ENDOCRINE DISORDERS The role of the endocannabinoid system in the neuroendocrine regulation of energy balance 25 CBD FOR ENDOCRINE DISORDERS CBD for children with Dravet’s and intractable seizures 25 CBD FOR ENDOCRINE DISORDERS Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy 25 CBD FOR ENDOCRINE DISORDERS Medicinal marijuana stops seizures, brings hope to a little girl 25 CBD FOR ENDOCRINE DISORDERS Cannabinoids for epilepsy 25 CBD FOR ENDOCRINE DISORDERS Cannabis, cannabidiol, and epilepsy – From receptors to clinical response 25 CBD FOR ENDOCRINE DISORDERS The non-psychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol ( CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability 25 CBD FOR ENDOCRINE DISORDERS Chronic administration of cannabidiol to healthy volunteers and epileptic patients 25 CBD FOR ENDOCRINE DISORDERS Endocannabinoid system protects against cryptogenic seizures 25 CBD FOR ENDOCRINE DISORDERS Seizing an opportunity for the endocannabinoid system 25 CBD FOR ENDOCRINE DISORDERS Cannabidiol: promise and pitfalls 25 CBD FOR ENDOCRINE DISORDERS Cannabidivarin (CBDV) suppressespentylenetetrazole (PTZ)-inducedincreases in epilepsy-related gene expression 25 CBD FOR ENDOCRINE DISORDERS Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures 25 CBD FOR ENDOCRINE DISORDERS Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo 25 CBD FOR ENDOCRINE DISORDERS Hypnotic and antiepileptic effects of cannabidiol 25 CBD FOR ENDOCRINE DISORDERS The cannabinoids as potential antiepileptics 25 CBD FOR ENDOCRINE DISORDERS Cannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats 5 26 CBD FOR FIBROMYALGIA Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? 26 CBD FOR FIBROMYALGIA Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life 26 CBD FOR FIBROMYALGIA Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia 26 CBD FOR FIBROMYALGIA Cannabinoids for fibromyalgia 26 CBD FOR FIBROMYALGIA Medical Cannabis for the Treatment of Fibromyalgia 4 27 CBD FOR GLAUCOMA Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite 27 CBD FOR GLAUCOMA Cannabinoids and glaucoma 27 CBD FOR GLAUCOMA The treatment of glaucoma using a non-psychoactive preparation of Cannabis sativa 27 CBD FOR GLAUCOMA Cannabinoids for treatment of glaucoma 7 28 CBD FOR HEART DISEASE Is the cardiovascular system a therapeutic target for cannabidiol? 28 CBD FOR HEART DISEASE Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion 28 CBD FOR HEART DISEASE Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy 28 CBD FOR HEART DISEASE The Effect of Cannabidiol on Ischemia/Reperfusion-Induced Ventricular Arrhythmias: The Role of Adenosine A1 Receptors 28 CBD FOR HEART DISEASE Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury 28 CBD FOR HEART DISEASE Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension 28 CBD FOR HEART DISEASE Oleamide: A fatty acid amide signaling molecule in the cardiovascular system? 6 29 CBD FOR HUNTINGTONS DISEASE Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease 29 CBD FOR HUNTINGTONS DISEASE Cannabinoids: Novel medicines for the treatment of Huntington’s disease 29 CBD FOR HUNTINGTONS DISEASE Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington’s disease: role of CB(1) and CB(2) receptors 29 CBD FOR HUNTINGTONS DISEASE Controlled clinical trial of cannabidiol in Huntington’s disease 29 CBD FOR HUNTINGTONS DISEASE Prospects for cannabinoid therapies in basal ganglia disorders 29 CBD FOR HUNTINGTONS DISEASE Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice 13 30 CBD FOR INFLAMMATION Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress 30 CBD FOR INFLAMMATION The endocannabinoid system: an emerging key player in inflammation 30 CBD FOR INFLAMMATION Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice 30 CBD FOR INFLAMMATION Cannabinoids, endocannabinoids, and related analogs in inflammation 30 CBD FOR INFLAMMATION Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor 30 CBD FOR INFLAMMATION Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors 30 CBD FOR INFLAMMATION Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis 30 CBD FOR INFLAMMATION Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation 30 CBD FOR INFLAMMATION Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement 30 CBD FOR INFLAMMATION Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption 30 CBD FOR INFLAMMATION Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation 30 CBD FOR INFLAMMATION Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death 30 CBD FOR INFLAMMATION Cannabinoids in clinical practice 9 31 CBD FOR IRRITABLE BOWEL SYNDROME Cannabidiol in inflammatory bowel diseases: A brief overview 31 CBD FOR IRRITABLE BOWEL SYNDROME Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis 31 CBD FOR IRRITABLE BOWEL SYNDROME Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? 31 CBD FOR IRRITABLE BOWEL SYNDROME Cannabinoid actions at TRPV channels: Effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation 31 CBD FOR IRRITABLE BOWEL SYNDROME Therapeutic potential of cannabinoid-based drugs 31 CBD FOR IRRITABLE BOWEL SYNDROME Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (Biochemical Pharmacology) 31 CBD FOR IRRITABLE BOWEL SYNDROME Cannabinoids and the gut: New developments and emerging concepts 31 CBD FOR IRRITABLE BOWEL SYNDROME Endocannabinoids and the gastrointestinal tract 31 CBD FOR IRRITABLE BOWEL SYNDROME Cannabinoids and gastrointestinal motility: Animal and human studies 4 32 CBD FOR KIDNEY DISEASE Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death 32 CBD FOR KIDNEY DISEASE Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay 32 CBD FOR KIDNEY DISEASE Is There a Legitimate Role for the Therapeutic Use of Cannabinoids for Symptom Management in Chronic Kidney Disease? 32 CBD FOR KIDNEY DISEASE The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases 7 33 CBD FOR LIVER DISEASE The endocannabinoid system and liver diseases 33 CBD FOR LIVER DISEASE Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death 33 CBD FOR LIVER DISEASE Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis 33 CBD FOR LIVER DISEASE Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats 33 CBD FOR LIVER DISEASE Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol 33 CBD FOR LIVER DISEASE Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice 33 CBD FOR LIVER DISEASE Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation 5 34 CBD FOR METABOLIC SYNDROME The impact of marijuana use on glucose, insulin, and insulin resistance among US adults 34 CBD FOR METABOLIC SYNDROME The potential use of cannabidiol in the therapy of metabolic syndrome 34 CBD FOR METABOLIC SYNDROME Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes 34 CBD FOR METABOLIC SYNDROME Metabolic syndrome in people with a psychotic illness: is cannabis protective? 34 CBD FOR METABOLIC SYNDROME Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome 5 35 CBD FOR MIGRAINES Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? 35 CBD FOR MIGRAINES Effects of anandamide in migraine: data from an animal model 35 CBD FOR MIGRAINES Cannabinoids and hallucinogens for headache 35 CBD FOR MIGRAINES The endocannabinoid system and migraine 35 CBD FOR MIGRAINES Variations in the cannabinoid receptor 1 gene predispose to migraine 6 36 CBD FOR MOOD DISORDERS Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders 36 CBD FOR MOOD DISORDERS The endocannabinoid system and the treatment of mood and anxiety disorders 36 CBD FOR MOOD DISORDERS The endocannabinoid system and psychiatric disorders 36 CBD FOR MOOD DISORDERS The endocannabinoid system in the regulation of emotions throughout lifespan: A discussion on therapeutic perspectives 36 CBD FOR MOOD DISORDERS Endocannabinoid system dysfunction in mood and related disorders 36 CBD FOR MOOD DISORDERS Effects of cannabidiol ( CBD) on regional cerebral blood flow 3 37 CBD FOR MOTION SICKNESS Motion sickness, stress and the endocannabinoid system 37 CBD FOR MOTION SICKNESS Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system 37 CBD FOR MOTION SICKNESS The Effects of Cannabidiol and Tetrahydrocannabinol on Motion‐Induced Emesis 10 38 CBD FOR MULTIPLE SCLEROSIS Sativex for the management of multiple sclerosis symptoms 38 CBD FOR MULTIPLE SCLEROSIS THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis 38 CBD FOR MULTIPLE SCLEROSIS Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity 38 CBD FOR MULTIPLE SCLEROSIS Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors 38 CBD FOR MULTIPLE SCLEROSIS Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial 38 CBD FOR MULTIPLE SCLEROSIS Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis 38 CBD FOR MULTIPLE SCLEROSIS Sativex long-term use: An open-label trial in patients with spasticity due to multiple sclerosis 38 CBD FOR MULTIPLE SCLEROSIS A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis 38 CBD FOR MULTIPLE SCLEROSIS Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain( 38 CBD FOR MULTIPLE SCLEROSIS Sativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain 6 39 CBD FOR NAUSEA Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus 39 CBD FOR NAUSEA Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation 39 CBD FOR NAUSEA Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol ( CBD) in rats and shrews 39 CBD FOR NAUSEA Regulation of nausea and vomiting by cannabinoids 39 CBD FOR NAUSEA Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats 39 CBD FOR NAUSEA Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting 5 40 CBD FOR NEURODEGENERATION Cannabidiol: A promising drug for neurodegenerative disorders? 40 CBD FOR NEURODEGENERATION Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid? 40 CBD FOR NEURODEGENERATION Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder 40 CBD FOR NEURODEGENERATION Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders 40 CBD FOR NEURODEGENERATION Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection 18 41 CBD FOR NEUROPATHIC PAIN Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain 41 CBD FOR NEUROPATHIC PAIN Sativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain 41 CBD FOR NEUROPATHIC PAIN Cannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine 41 CBD FOR NEUROPATHIC PAIN Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial 41 CBD FOR NEUROPATHIC PAIN Cannabinoids for neuropathic pain 41 CBD FOR NEUROPATHIC PAIN Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue 41 CBD FOR NEUROPATHIC PAIN Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial 41 CBD FOR NEUROPATHIC PAIN The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain 41 CBD FOR NEUROPATHIC PAIN Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation 41 CBD FOR NEUROPATHIC PAIN Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy 41 CBD FOR NEUROPATHIC PAIN Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: Mechanisms involved 41 CBD FOR NEUROPATHIC PAIN Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action 41 CBD FOR NEUROPATHIC PAIN Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors 41 CBD FOR NEUROPATHIC PAIN Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes 41 CBD FOR NEUROPATHIC PAIN Cannabinoids in the management of difficult to treat pain 41 CBD FOR NEUROPATHIC PAIN Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain 41 CBD FOR NEUROPATHIC PAIN Marijuana extract helps prevent chemo pain 41 CBD FOR NEUROPATHIC PAIN Pot users less likely to take painkillers 6 42 CBD FOR OBESITY The impact of marijuana use on glucose, insulin, and insulin resistance among US adults 42 CBD FOR OBESITY Cannabinol and cannabidiol exert opposing effects on rat feeding patterns 42 CBD FOR OBESITY Cannabis and Δ9-tetrahydrocannabinol (THC) for weight loss? 42 CBD FOR OBESITY The endocannabinoid system in obesity and type 2 diabetes 42 CBD FOR OBESITY Role of the endocannabinoid system in abdominal obesity and the implications for cardiovascular risk 42 CBD FOR OBESITY Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes 3 43 CBD FOR OCD Plasma and brain pharmacokinetic profile of cannabidiol ( CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour (PubMed) 43 CBD FOR OCD Plasma and brain pharmacokinetic profile of cannabidiol ( CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour 43 CBD FOR OCD Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice 7 44 CBD FOR PARKINSONS DISEASE Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial 44 CBD FOR PARKINSONS DISEASE Prospects for cannabinoid therapies in basal ganglia disorders 44 CBD FOR PARKINSONS DISEASE Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: Importance of antioxidant and cannabinoid receptor-independent properties 44 CBD FOR PARKINSONS DISEASE Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease 44 CBD FOR PARKINSONS DISEASE Cannabidiol for the treatment of psychosis in Parkinson’s disease 44 CBD FOR PARKINSONS DISEASE Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease 44 CBD FOR PARKINSONS DISEASE Therapeutic potential of cannabinoids in CNS disease 3 45 CBD FOR PRION Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity 45 CBD FOR PRION Cannabidiol: A prion therapy for mice? 45 CBD FOR PRION Alteration of the endocannabinoid system in mouse brain during prion disease 13 46 CBD FOR PTSD The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD 46 CBD FOR PTSD Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks 46 CBD FOR PTSD Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear 46 CBD FOR PTSD Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors 46 CBD FOR PTSD Stress switches cannabinoid type-1 (CB1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis 46 CBD FOR PTSD Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence 46 CBD FOR PTSD Cannabinoid modulation of fear extinction brain circuits: A novel target to advance anxiety treatment 46 CBD FOR PTSD The endocannabinoid system and extinction learning 46 CBD FOR PTSD A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers 46 CBD FOR PTSD Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit 46 CBD FOR PTSD Non-antidepressant long-term treatment in post-traumatic stress disorder 46 CBD FOR PTSD The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: Involvement of the endocannabinoid system 46 CBD FOR PTSD Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors 4 47 CBD FOR RHEUMATISM Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress 47 CBD FOR RHEUMATISM Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases 47 CBD FOR RHEUMATISM Clinical Implications for Cannabinoid Use in the Rheumatic Diseases 47 CBD FOR RHEUMATISM Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases 12 48 CBD FOR SCHIZOPHRENIA Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug 48 CBD FOR SCHIZOPHRENIA Cannabidiol as a potential treatment for psychosis 48 CBD FOR SCHIZOPHRENIA Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia 48 CBD FOR SCHIZOPHRENIA Medical use of cannabis. Cannabidiol: A new light for schizophrenia? 48 CBD FOR SCHIZOPHRENIA A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation 48 CBD FOR SCHIZOPHRENIA Peripheral endocannabinoid system dysregulation in first-episode psychosis 48 CBD FOR SCHIZOPHRENIA Cannabinoids and schizophrenia: Therapeutic prospects 48 CBD FOR SCHIZOPHRENIA Antipsychotic-like effects of cannabidiol and rimonabant: Systematic review of animal and human studies 48 CBD FOR SCHIZOPHRENIA Cannabidiol monotherapy for treatment-resistant schizophrenia 48 CBD FOR SCHIZOPHRENIA Cannabis with high cannabidiol content is associated with fewer psychotic experiences 48 CBD FOR SCHIZOPHRENIA Marijuana compound treats schizophrenia with few side effects: Clinical trial 48 CBD FOR SCHIZOPHRENIA Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia? 3 49 CBD FOR SICKLE CELL ANEMIA Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: Modulation by cannabinoids 49 CBD FOR SICKLE CELL ANEMIA Cannabis use in sickle cell disease: A questionnaire study 49 CBD FOR SICKLE CELL ANEMIA Cannabinoid Receptor-Specific Mechanisms To Alleviate Pain In Sickle Cell Anemia Via Inhibition Of Mast Cell Activation And Neurogenic Inflammation 8 50 CBD FOR SKIN CONDITIONS Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis 50 CBD FOR SKIN CONDITIONS Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes 50 CBD FOR SKIN CONDITIONS The endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities 50 CBD FOR SKIN CONDITIONS Epigenetic control of skin differentiation genes by phytocannabinoids 50 CBD FOR SKIN CONDITIONS Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1 50 CBD FOR SKIN CONDITIONS Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation 50 CBD FOR SKIN CONDITIONS Attenuation of allergic contact dermatitis through the endocannabinoid system 50 CBD FOR SKIN CONDITIONS Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus 7 51 CBD FOR SLEEP DISORDERS The nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent 51 CBD FOR SLEEP DISORDERS Cannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine 51 CBD FOR SLEEP DISORDERS Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats 51 CBD FOR SLEEP DISORDERS Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults 51 CBD FOR SLEEP DISORDERS Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats 51 CBD FOR SLEEP DISORDERS Endocannabinoid modulation of cortical up-states and NREM sleep 51 CBD FOR SLEEP DISORDERS Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat 4 52 CBD FOR SPINAL CORD INJURY Cannabidiol-treated rats exhibited higher motor score after cryogenic spinal cord injury 52 CBD FOR SPINAL CORD INJURY Cannabis effect on spasticity in spinal cord injury 52 CBD FOR SPINAL CORD INJURY An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease 52 CBD FOR SPINAL CORD INJURY Modulation of Inflammatory Responses by a Cannabinoid-2–Selective Agonist after Spinal Cord Injury 13 53 CBD FOR STRESS Endogenous cannabinoid signaling is essential for stress adaptation 53 CBD FOR STRESS Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders 53 CBD FOR STRESS Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output 53 CBD FOR STRESS Neuromodulators, stress and plasticity: a role for endocannabinoid signalling 53 CBD FOR STRESS Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress 53 CBD FOR STRESS Endocannabinoids and stress 53 CBD FOR STRESS Stress regulates endocannabinoid-CB1 receptor signaling 53 CBD FOR STRESS Chronic Stress Impairs α1-Adrenoceptor-Induced Endocannabinoid-Dependent Synaptic Plasticity in the Dorsal Raphe Nucleus 53 CBD FOR STRESS Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance 53 CBD FOR STRESS Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression 53 CBD FOR STRESS Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory 53 CBD FOR STRESS The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system 53 CBD FOR STRESS Low-frequency stimulation evokes serotonin release in the nucleus accumbens and induces long-term depression via production of endocannabinoid 6 54 CBD FOR STROKE/TBI Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury 54 CBD FOR STROKE/TBI Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism 54 CBD FOR STROKE/TBI Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism ( 54 CBD FOR STROKE/TBI Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function 54 CBD FOR STROKE/TBI Protective Effects of Cannabidiol Against Hippocampal Cell Death and Cognitive Impairment Induced by Bilateral Common Carotid Artery Occlusion in Mice 54 CBD FOR STROKE/TBI Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance